Real world evidence retrospective study to evaluate the safety and efficacy of an amniotic membrane allograft for venous leg ulcers in a post-acute care setting
DOI:
https://doi.org/10.63676/njqm6t61Keywords:
chronic wound, wound healing, Cellular, acellular, and matrix-like products , venous leg ulcer, amniotic membrane allograftAbstract
Aims: To evaluate the reduction of wound size in venous leg ulcers (VLUs) after amniotic membrane allograft (AmnioBurgeon (OneBiotech, USA)) treatment.
Methods: Single-center retrospective database study of patients treated with an amniotic membrane allograft for VLUs. Wound area was measured prior to each allograft application, and the change in wound area after each application was evaluated over the progression of therapy.
Results: In total, 38 patients with 43 VLUs were treated weekly with AmnioBurgeon with an average wound size of 9.4 cm2. During the treatment course, 6% of the wounds completely healed with a mean time to healing of 38.8 days. 46% of the wounds partially healed with at least 50% or greater area reduction within 17.6 days on average. By the 4th week, 42% of wounds achieved 50% or more reduction in their size. Our treatment group included VLUs ranging between 0.25 cm2 and 25 cm2, achieving significant wound area reduction, indicating wound healing trajectory.
Conclusion: Amniotic membrane allograft is an effective treatment for VLUs.
References
Sen CK. Human Wounds and Its Burden: An Updated Compendium of Estimates. Adv Wound Care (New Rochelle). 2019;8(2):39-48. https://doi.org/10.1089/wound.2019.0946
Mostow EN, Haraway GD, Dalsing M, Hodde JP, King D; OASIS Venus Ulcer Study Group. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg. 2005;41(5):837-843. https://doi.org/10.1016/j.jvs.2005.01.042
Bonkemeyer Millan S, Gan R, Townsend PE. Venous Ulcers: Diagnosis and Treatment. Am Fam Physician. 2019;100(5):298-305.
Gillespie DL; Writing Group III of the Pacific Vascular Symposium 6, Kistner B, et al. Venous ulcer diagnosis, treatment, and prevention of recurrences. J Vasc Surg. 2010;52(5 Suppl):8S-14S. https://doi.org/10.1016/j.jvs.2010.05.068
Olin JW, Beusterien KM, Childs MB, Seavey C, McHugh L, Griffiths RI. Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study. Vasc Med. 1999;4(1):1-7. https://doi.org/10.1177/1358836X9900400101
Falanga V, Isseroff RR, Soulika AM, et al. Chronic wounds. Nat Rev Dis Primers. 2022;8(1):50. Published 2022 Jul 21. https://doi.org/10.1038/s41572-022-00377-3
Xie T, Ye J, Rerkasem K, Mani R. The venous ulcer continues to be a clinical challenge: an update. Burns Trauma. 2018;6:18. https://doi.org/10.1186/s41038-018-0119-y
Salenius JE, Suntila M, Ahti T, et al. Long-term Mortality among Patients with Chronic Ulcers. Acta Derm Venereol. 2021;101(5):adv00455. https://doi.org/10.2340/00015555-3803
Margolis DJ, Bilker W, Santanna J, Baumgarten M. Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol. 2002;46(3):381-386. https://doi.org/10.1067/mjd.2002.121739
Grzela T, Bialoszewska A. Genetic risk factors of chronic venous leg ulceration: Can molecular screening aid in the prevention of chronic venous insufficiency complications?. Mol Med Rep. 2010;3(2):205-211. https://doi.org/10.3892/mmr_00000241
Patton D, Avsar P, Sayeh A, et al. A systematic review of the impact of compression therapy on quality of life and pain among people with a venous leg ulcer. Int Wound J. 2024;21(3):e14816. https://doi.org/10.1111/iwj.14816
Kirsner RS, Baquerizo Nole KL, Fox JD, Liu SN. Healing refractory venous ulcers: new treatments offer hope. J Invest Dermatol. 2015;135(1):19-23. https://doi.org/10.1038/jid.2014.444
Chi YW, Raffetto JD. Venous leg ulceration pathophysiology and evidence based treatment. Vasc Med. 2015;20(2):168-181. https://doi.org/10.1177/1358863X14568677
Crawford JM, Lal BK, Durán WN, Pappas PJ. Pathophysiology of venous ulceration. J Vasc Surg Venous Lymphat Disord. 2017;5(4):596-605. https://doi.org/10.1016/j.jvsv.2017.03.015
Malanin K. About the pathophysiology of venous leg ulceration. J Am Acad Dermatol. 2002;47(1):157-158. https://doi.org/10.1067/mjd.2002.120577
Raffetto JD, Ligi D, Maniscalco R, Khalil RA, Mannello F. Why Venous Leg Ulcers Have Difficulty Healing: Overview on Pathophysiology, Clinical Consequences, and Treatment. J Clin Med. 2020;10(1):29. https://doi.org/10.3390/jcm10010029
Margolis DJ, Berlin JA, Strom BL. Risk factors associated with the failure of a venous leg ulcer to heal. Arch Dermatol. 1999;135(8):920-926. https://doi.org/10.1001/archderm.135.8.920
Stevenson EM, Coda A, Bourke MDJ. Investigating low rates of compliance to graduated compression therapy for chronic venous insufficiency: A systematic review. Int Wound J. 2024;21(4):e14833. https://doi.org/10.1111/iwj.14833
Weller CD, Richards C, Turnour L, Team V. Patient Explanation of Adherence and Non-Adherence to Venous Leg Ulcer Treatment: A Qualitative Study. Front Pharmacol. 2021;12:663570. https://doi.org/10.3389/fphar.2021.663570
Bar L, Marks D, Brandis S. Developing a Suite of Resources to Improve Patient Adherence to Compression Stockings: Application of Behavior Change Theory. Patient Prefer Adherence. 2023;17:51-66. https://doi.org/10.2147/PPA.S390123
Jones JE, Nelson EA, Al-Hity A. Skin grafting for venous leg ulcers. Cochrane Database Syst Rev. 2013;2013(1):CD001737. https://doi.org/10.1002/14651858.CD001737.pub4
Pan J, Hu X, Yin H, Zhang C, Yan Z. Effectiveness of different types of skin grafting for treating venous leg ulcers: A protocol for systematic review and network meta-analysis. Medicine (Baltimore). 2021;100(15):e25597. https://doi.org/10.1097/MD.0000000000025597
Deng X, Gould M, Ali MA. A review of current advancements for wound healing: Biomaterial applications and medical devices. J Biomed Mater Res B Appl Biomater. 2022;110(11):2542-2573. https://doi.org/10.1002/jbm.b.35086
Bianchi C, Cazzell S, Vayser D, et al. A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion/chorion membrane (EpiFix® ) allograft for the treatment of venous leg ulcers. Int Wound J. 2018;15(1):114-122. https://doi.org/10.1111/iwj.12843
Serena TE, Orgill DP, Armstrong DG, et al. A Multicenter, Randomized, Controlled, Clinical Trial Evaluating Dehydrated Human Amniotic Membrane in the Treatment of Venous Leg Ulcers. Plast Reconstr Surg. 2022;150(5):1128-1136. https://doi.org/10.1097/PRS.0000000000009650
Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 1999;7(4):201-207. https://doi.org/10.1046/j.1524-475x.1999.00201.x
Alomairi AA, Alhatlani RA, Alharbi SM, et al. Assessing the application and effectiveness of human amniotic membrane in the management of venous and diabetic ulcers: a systematic review and meta-analysis of randomized controlled trials. Cureus. 2024;16(3):e56659. Published 2024 Mar 21. https://doi.org/10.7759/cureus.56659
Shaydakov ME, Ting W, Sadek M, et al. Review of the current evidence for topical treatment for venous leg ulcers. J Vasc Surg Venous Lymphat Disord. 2022;10(1):241-247.e15. https://doi.org/10.1016/j.jvsv.2021.06.010
Protzman NM, Mao Y, Long D, et al. Placental-Derived Biomaterials and Their Application to Wound Healing: A Review. Bioengineering (Basel). 2023;10(7):829. https://doi.org/10.3390/bioengineering10070829
Vecin NM, Kirsner RS. Skin substitutes as treatment for chronic wounds: current and future directions. Front Med (Lausanne). 2023;10:1154567. https://doi.org/10.3389/fmed.2023.1154567
Zelen CM, Serena TE, Snyder RJ. A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion/chorion membrane allograft in the management of diabetic foot ulcers. Int Wound J. 2014;11(2):122-128. https://doi.org/10.1111/iwj.12242
Lavery LA, Suludere MA, Raspovic K, Crisologo PA, Johnson MJ, Tarricone AN. Randomized Controlled Trial to Compare AmnioExcel Human Amniotic Allograft in Weekly Versus Biweekly Treatment of Diabetic Foot Ulcers. Int J Low Extrem Wounds. https://doi.org/10.1177/15347346241276697
Harding K. Challenging passivity in venous leg ulcer care - the ABC model of management. Int Wound J. 2016;13(6):1378-1384. https://doi.org/10.1111/iwj.12608
Serena TE, Yaakov R, DiMarco D, et al. Dehydrated human amnion/chorion membrane treatment of venous leg ulcers: correlation between 4-week and 24-week outcomes. J Wound Care. 2015;24(11):530-534. https://doi.org/10.12968/jowc.2015.24.11.530
Gwilym BL, Mazumdar E, Naik G, Tolley T, Harding K, Bosanquet DC. Initial Reduction in Ulcer Size As a Prognostic Indicator for Complete Wound Healing: A Systematic Review of Diabetic Foot and Venous Leg Ulcers. Adv Wound Care (New Rochelle). 2023;12(6):327-338. https://doi.org/10.1089/wound.2021.0203
Masiello G, Franzini M, Tirelli U, et al. Successful treatment of severe venous leg ulcers and diabetic foot ulcers using ozone. J Vasc Surg Venous Lymphat Disord. 2025;13(6):102278. https://doi.org/10.1016/j.jvsv.2025.102278
Fife CE, Horn SD. The Wound Healing Index for Predicting Venous Leg Ulcer Outcome. Adv Wound Care (New Rochelle). 2020;9(2):68-77. https://doi.org/10.1089/wound.2019.1038
Downloads
Published
Issue
Section
License
Copyright (c) 2025 International Journal of Tissue Repair
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
